Rabbit Recombinant Monoclonal ACAT1 antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 20 publications.
View Alternative Names
ACAT, MAT, ACAT1, Acetoacetyl-CoA thiolase, T2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACAT1 antibody [EPR10359] (AB168342)
ab168342 showing +ve staining in Human normal colon tissue.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACAT1 antibody [EPR10359] (AB168342)
Immunohistochemical analysis of paraffin-embedded Human heart tissue labeling ACAT1 with ab168342 at 1/50 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACAT1 antibody [EPR10359] (AB168342)
ab168342 showing +ve staining in Human papillary adenocarcinoma of thyroid gland tissue.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACAT1 antibody [EPR10359] (AB168342)
Immunohistochemical analysis of paraffin-embedded Human liver tissue labeling ACAT1 with ab168342 at 1/50 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACAT1 antibody [EPR10359] (AB168342)
ab168342 showing +ve staining in Human normal kidney tissue.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACAT1 antibody [EPR10359] (AB168342)
ab168342 showing +ve staining in Human ovarian carcinoma tissue.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IP
Unknown
Immunoprecipitation - Anti-ACAT1 antibody [EPR10359] (AB168342)
Western blot analysis labelling ACAT1 on immunoprecipitation pellet from Human fetal liver lysate using ab168342 at 1/10 dilution, and HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG.
All lanes:
Immunoprecipitation - Anti-ACAT1 antibody [EPR10359] (ab168342)
Predicted band size: 45 kDa
false
- WB
Lab
Western blot - Anti-ACAT1 antibody [EPR10359] (AB168342)
Lanes 1 - 4 : Merged signal (red and green). Green - ab168342 observed at 45 kDa. Red - loading control, ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.
ab168342 was shown to react with ACAT1 in western blot. The band observed in the CRISPR/Cas9 edited lysate lane below 45 kDa is likely to represent a truncated form. This has not been investigated further. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab168342 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-ACAT1 antibody [EPR10359] (ab168342) at 1/1000 dilution
Lane 1:
Wild-type SW480 cell lysate at 20 µg
Lane 2:
ACAT1 CRISPR/Cas9 edited SW480 cell lysate at 20 µg
Lane 3:
HepG2 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
- WB
Lab
Western blot - Anti-ACAT1 antibody [EPR10359] (AB168342)
Lanes 1 - 4 : Merged signal (red and green). Green - ab168342 observed at 45 kDa. Red - loading control, ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.
ab168342 was shown to react with ACAT1 in western blot. The band observed in the knockout cell line ab269621 (knockout cell lysate ab272431) lane below 45 kDa is likely to represent a truncated form. This has not been investigated further. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab168342 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-ACAT1 antibody [EPR10359] (ab168342) at 1/1000 dilution
Lane 1:
Wild-type SW480 cell lysate at 20 µg
Lane 2:
ACAT1 knockout SW480 cell lysate at 20 µg
Lane 2:
Western blot - Human ACAT1 knockout SW480 cell line (<a href='/en-us/products/cell-lines/human-acat1-knockout-sw480-cell-line-ab269621'>ab269621</a>)
Lane 3:
HepG2 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
- WB
Unknown
Western blot - Anti-ACAT1 antibody [EPR10359] (AB168342)
All lanes:
Western blot - Anti-ACAT1 antibody [EPR10359] (ab168342) at 1/1000 dilution
Lane 1:
Human fetal liver lysates at 10 µg
Lane 2:
HepG2 lysates at 10 µg
Lane 3:
SKBR-3 lysates at 10 µg
Lane 4:
THP-1 lysates at 10 µg
Lane 5:
Human fetal kidney lysates at 10 µg
Predicted band size: 45 kDa
false
Related conjugates and formulations (1)
-
Anti-ACAT1 antibody [EPR10359] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ACAT1 plays a central role in cellular cholesterol homeostasis and in preventing cholesterol-induced cytotoxicity by converting free cholesterol into inert cholesteryl esters for storage. It functions as a homotetramer suggesting that it works as a part of a larger protein complex. ACAT1 influences lipid accumulation within cells and mediates the regulation of cholesterol levels which is vital for maintaining membrane integrity and cellular function.
Pathways
ACAT1 participates in the cholesterol metabolism pathway and the lipid biosynthesis pathway. It interacts with proteins such as LDLR (low-density lipoprotein receptor) by controlling the availability of free cholesterol within cells. These pathways are critical in maintaining lipid balance and influencing lipoprotein metabolism. ACAT1's enzymatic activity impacts how cells manage cholesterol influx and storage linking to broader lipid regulation networks.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (20)
Recent publications for all applications. Explore the full list and refine your search
Cell death discovery 11:193 PubMed40268915
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nutrients 16: PubMed38257179
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biochemistry 62:1274-1286 PubMed36920305
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed36232940
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:927118 PubMed35912092
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the American Heart Association 10:e020729 PubMed34583524
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 24:711-727 PubMed33996254
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer therapeutics 20:398-409 PubMed33298586
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 8:580599 PubMed33330456
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:20314 PubMed33219259
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com